Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) Income from Non-Controlling Interests (2020 - 2025)

Historic Income from Non-Controlling Interests for ImmunityBio (IBRX) over the last 6 years, with Q3 2025 value amounting to -$21000.0.

  • ImmunityBio's Income from Non-Controlling Interests rose 869.57% to -$21000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$77000.0, marking a year-over-year increase of 1046.51%. This contributed to the annual value of -$81000.0 for FY2024, which is 8765.24% up from last year.
  • Latest data reveals that ImmunityBio reported Income from Non-Controlling Interests of -$21000.0 as of Q3 2025, which was up 869.57% from -$19000.0 recorded in Q2 2025.
  • ImmunityBio's 5-year Income from Non-Controlling Interests high stood at -$17000.0 for Q4 2024, and its period low was -$1.1 million during Q2 2021.
  • Moreover, its 5-year median value for Income from Non-Controlling Interests was -$111000.0 (2022), whereas its average is -$242526.3.
  • As far as peak fluctuations go, ImmunityBio's Income from Non-Controlling Interests plummeted by 12287.92% in 2021, and later surged by 9401.2% in 2024.
  • ImmunityBio's Income from Non-Controlling Interests (Quarter) stood at -$294000.0 in 2021, then soared by 62.24% to -$111000.0 in 2022, then surged by 80.18% to -$22000.0 in 2023, then rose by 22.73% to -$17000.0 in 2024, then dropped by 23.53% to -$21000.0 in 2025.
  • Its last three reported values are -$21000.0 in Q3 2025, -$19000.0 for Q2 2025, and -$20000.0 during Q1 2025.